Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Because GLP-1 agonists seem to reduce patients’ desire for food, it isn’t surprising that they might also shrink or even ...

Discover the impact of dopamine on the brain's reward circuit, from pleasure to addiction, and how to find balance.

Researchers at the University of Michigan have developed a mathematical model that reveals how our circadian rhythms can have ...

TikTok’s “dopamine detox” trend promises to rewire your brain — but science says that’s not how dopamine works. Here’s what ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

Studies combing through past patient data have made a similar link between drugs like Ozempic and a loss of appetite for more ...

The 2025 AASM guidelines recommend iron supplementation as the first-line treatment for RLS when ferritin levels are below 75 ng/mL. Dopamine agonists like ropinirole can reduce RLS symptoms but carry ...

Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires ...

Unveil the science behind staying sober. Explore key insights and sustainable strategies backed by research for lasting recovery.

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

Remarkable scientific progress over the past five decades has helped us develop knowledge of how drugs of abuse induce pleasure, reinforce use, and lead to the compulsive self-administration we call ...